These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1997797)

  • 1. Conservative treatment of adenocarcinoma of the lower rectum.
    Elias EG; Parnes HL
    Md Med J; 1991 Feb; 40(2):87-8. PubMed ID: 1997797
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectal cancer at the crossroads: the dilemma of clinically staged T3, N0, M0 disease.
    Kachnic LA; Hong TS; Ryan DP
    J Clin Oncol; 2008 Jan; 26(3):350-1. PubMed ID: 18202407
    [No Abstract]   [Full Text] [Related]  

  • 3. Multidisciplinary treatment of synchronous primary rectal and prostate cancers.
    Colonias A; Farinash L; Miller L; Jones S; Medich DS; Greenberg L; Miller R; Parda DS
    Nat Clin Pract Oncol; 2005 May; 2(5):271-4; quiz 1 p following 274. PubMed ID: 16264963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete pathologic response after chemoradiation for rectal cancer.
    Henri M; Latulippe JF; Heyen F; Dubé S
    Dis Colon Rectum; 2005 May; 48(5):1097-8; author reply 1098. PubMed ID: 15933896
    [No Abstract]   [Full Text] [Related]  

  • 5. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rectal adenocarcinoma with rhabdoid phenotype.
    Macák J; Kodet R
    Pathologica; 1995 Dec; 87(6):696-9. PubMed ID: 8927435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histologic response after neoadjuvant therapy in rectal adenocarcinoma: own experience and review of the literature].
    Mátrai Z; Lövey J; Hitre E; Orosz Z; Gödény M; Péley G; Sulyok Z; Rényi Vámos F; Farkas E; Köves I
    Orv Hetil; 2006 Oct; 147(42):2011-20. PubMed ID: 17165600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of distal intramural spread after preoperative combined-modality therapy for adenocarcinoma of the rectum: what is now the appropriate distal resection margin?
    Mezhir JJ; Smith KD; Fichera A; Hart J; Posner MC; Hurst RD
    Surgery; 2005 Oct; 138(4):658-63; discussion 663-4. PubMed ID: 16269294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative staging and treatment options in T1 rectal adenocarcinoma.
    Baatrup G; Endreseth BH; Isaksen V; Kjellmo A; Tveit KM; Nesbakken A
    Acta Oncol; 2009; 48(3):328-42. PubMed ID: 19180365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status.
    Read TE; Andujar JE; Caushaj PF; Johnston DR; Dietz DW; Myerson RJ; Fleshman JW; Birnbaum EH; Mutch MG; Kodner IJ
    Dis Colon Rectum; 2004 Jun; 47(6):825-31. PubMed ID: 15108025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined modality therapy in low risk (T2N0) rectal cancer.
    Coco C; Magistrelli P; Netri G; Cogliandolo S; Carbone L; Morganti AG; Ziccarelli L; Valentini V
    Rays; 1995; 20(2):156-64. PubMed ID: 7480864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer.
    Sadahiro S; Suzuki T; Ishikawa K; Fukasawa M; Saguchi T; Yasuda S; Makuuchi H; Murayama C; Ohizumi Y
    Eur J Surg Oncol; 2004 Sep; 30(7):750-8. PubMed ID: 15296989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and imaging of low rectal carcinoma.
    Salerno G; Daniels I; Heald RJ; Brown G; Moran BJ
    Surg Oncol; 2004; 13(2-3):55-61. PubMed ID: 15572087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of cancer of the rectum].
    Malafosse M
    Rev Prat; 1986 Sep; 36(41):2383-7. PubMed ID: 3787140
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
    Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
    Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal cancer in the young patient.
    Endreseth BH; Romundstad P; Myrvold HE; Hestvik UE; Bjerkeset T; Wibe A;
    Dis Colon Rectum; 2006 Jul; 49(7):993-1001. PubMed ID: 16741599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphincter preservation therapy for rectal cancer.
    Aitken C; Breen E; Mamon HJ
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
    Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
    Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving survival in patients with rectal cancer.
    Gilman CJ
    Am Fam Physician; 1984 Jan; 29(1):165-9. PubMed ID: 6695642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.